ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 657676 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 657676; 2) Community: the network communities that were significantly associated with the response to NSC 657676; 3) Molecule: the relationships between components within communities and NSC 657676; 4) MDR: the compounds that were significantly associated with the NSC 657676.

NSC Compound Enrichment Correlation
NSC 755295 2-(1-(3-chlorophenylsulfonyl)-1H-indol-3-yl)-2-oxo-N-(pyridin-4-yl)acetamide 0.0260391472224207 0.058189149
NSC 756248 GW513184X 0.0260391472224207 0.049348272
NSC 760474 2k2S,S? 0.0260391472224207 -0.013035752
NSC 134459 Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) 0.0267520285931239 -0.061680576
NSC 168516 Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- 0.0267520285931239 -0.25173479
NSC 175493 Iron, carbonyl(.eta.(5)-2,4-cyclopentadien-1-yl)(dimethylcarbamodithioato-S,S')- 0.0267520285931239 -0.065709443
NSC 176323 Camptothecin Derivative 0.0267520285931239 0.15090149
NSC 287069 Epicorazine A 0.0267520285931239 -0.17419604
NSC 295499 Camptothecin Derivative 0.0267520285931239 0.28588568
NSC 31780 3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) 0.0267520285931239 -0.16968315
Total:108  Current:66    [First] [Prev] [Next] [Last]